Tirzepatide monograph · Evidence review
Tirzepatide Storage: How Long Out of the Fridge?
Per the FDA label, an unopened tirzepatide pen or vial can sit at room temperature (≤86°F) for up to 21 days. Never refreeze it. The exact rules, quoted.
Researched & written by Alan Pierce · last updated
Clinical Pharmacology Writer
On this page
Editorial pick
CoreAge Rx
$149/mo flat
Doctor-reviewed tirzepatide with one flat price and built-in human support.
Check availability- vs median
- $50/mo below the $199 median
- Market
- $99–$399/mo across 25 providers
- Brand from
- $349/mo
- Dispensed
- Compounded tirzepatide (503A)
Advertising disclosure · we may earn a commission at no extra cost to you.
Popular alternative
Ageless
Broad compounded storefront pairing $169/month injectable tirzepatide with a rare oral-drop option — plus NAD+, sermorelin, and TRT under one roof.
$169/mo injectable
Check Ageless availabilityTirzepatide — sold as Zepbound and Mounjaro — is normally a refrigerated medicine, so the practical questions come up fast: Did I ruin it by leaving it on the counter? How long can it travel without a cold pack? What if it froze? The good news is that the FDA prescribing information answers these precisely, and the rules are identical for both brands because they are the same drug. This guide quotes those rules so you can act on the actual label, not a forum guess.
A note up front: these are the manufacturer's labeled storage instructions, summarized for general information. Always follow the Instructions for Use that came with your specific pen or vial, and call your pharmacist if you are unsure whether a dose is still safe to use.
The single-dose pen and vial: refrigerate at 36–46°F
The default for the single-dose pen and single-dose vial is the refrigerator. The label says to "Store ZEPBOUND single-dose pen and single-dose vial in a refrigerator at 2°C to 8°C (36°F to 46°F)"1. The Mounjaro label carries word-for-word the same instruction2 — one more sign that these are the same molecule with two names, as we cover in Mounjaro vs Zepbound.
So the baseline is simple: keep it in the fridge, in its original carton to protect it from light, until you need it.
Out of the fridge: up to 21 days at or below 86°F
This is the question most people are really asking. Per the label, "each single-dose pen or single-dose vial can be stored unrefrigerated at temperatures not to exceed 30°C (86°F) for up to a total of 21 days"1. After that, "Discard single-dose pen and single-dose vial after a total of 21 days at room temperature"1.
Two words in that sentence matter. "Total" means the 21 days is cumulative — the unrefrigerated time adds up across the life of that pen or vial; you cannot reset the clock by putting it back in the fridge for a while. And "not to exceed 86°F (30°C)" is a hard ceiling: a hot car, a sunny windowsill, or a beach bag can blow past 86°F quickly, and heat above that limit is not covered by the 21-day allowance. The label is explicit to "Protect ZEPBOUND from heat and light"1.
§ Table 1 — Single-Dose Storage Limits
| Condition | Single-dose pen / vial rule |
|---|---|
| Refrigerated (36–46°F / 2–8°C) | Default storage; keep until expiration, in original carton, protected from light. |
| Room temp (≤86°F / ≤30°C) | Allowed up to a TOTAL of 21 cumulative days; discard after that. |
| Above 86°F / 30°C | Not covered — protect from heat; do not exceed the 86°F ceiling. |
| Frozen | Do not use. Discard. No refreeze, no thaw-and-use exception. |
| Visual check | Must be clear, colorless to slightly yellow, no particles — else discard. |
Never refreeze — and discard if it has frozen
Freezing is the bright line. The label states plainly: "Do not freeze ZEPBOUND. Do not use ZEPBOUND if frozen"1. The Mounjaro label is identical2. There is no thaw-and-use exception. If your pen or vial has frozen — a fridge set too cold, a checked bag in a cold cargo hold, a cold pack pressed directly against it — it should be discarded, not thawed and injected.
This is why a refrigerator that runs too cold can be as much of a problem as one that is too warm. Keep tirzepatide in the main body of the fridge, not against the back wall or in a spot where it can freeze.
Inspect before every injection: clear, colorless, no particles
Even within the temperature rules, the label adds a visual check before you inject. You should make sure the medicine "is not frozen, is not cloudy, is colorless to slightly yellow, [and] does not have particles"1. If it is cloudy, discolored, or has particles in it, do not use it — that is a sign the medicine may have been compromised, regardless of how it was stored.
In short: if it has frozen, looks cloudy, or has anything floating in it, throw it away and use a different dose.
§ Note — Storage Quick Rules
Tirzepatide out of the fridge, by the label
- Default: refrigerate at 36–46°F (2–8°C) in the original carton, away from light.
- Out of the fridge: up to a TOTAL of 21 cumulative days, only if it stays at or below 86°F (30°C).
- The 21-day clock is cumulative — re-refrigerating does not reset it.
- Never refreeze; discard any dose that has frozen (no thaw-and-use exception).
- Inspect every time: clear, colorless to slightly yellow, no particles — otherwise discard.
- Identical rules for Zepbound and Mounjaro; when unsure, ask your pharmacist.
A note on multi-dose vials and KwikPens
The single-dose figures above cover the most common Zepbound and Mounjaro presentations. The multi-dose vial and single-patient-use KwikPen have their own rules: unopened, they can be kept until the expiration date if refrigerated, but if stored at room temperature (up to 86°F) they should be thrown away after 30 days; once opened (in use), they are stored in the original carton either refrigerated or at room temperature for a defined in-use window1. Always check the Instructions for Use for your specific product, because the in-use limits differ by presentation.
The honest bottom line
For the single-dose pen and vial — the forms most people use — the rules are clear and worth memorizing: keep tirzepatide refrigerated at 36–46°F; if it is out of the fridge, it is good for up to a total of 21 cumulative days as long as it never exceeds 86°F; never refreeze it, and discard any dose that has frozen; and always inspect it to be clear and colorless with no particles before injecting. These instructions are identical for Zepbound and Mounjaro because they are the same drug. When in doubt about a dose that got too warm, too cold, or looks off, the safest move is to call your pharmacist rather than gamble on a compromised injection. For how to give the shot once it is at the right temperature, see how to inject Zepbound; for the full dose schedule, our tirzepatide dosage chart; for the broader evidence picture, the tirzepatide evidence guide; and to weigh providers and pharmacy access, our best tirzepatide overview.
Frequently asked questions
How long can tirzepatide stay out of the fridge?
Per the FDA label, a single-dose pen or vial can be stored unrefrigerated for up to a total of 21 days, as long as the temperature never exceeds 86°F (30°C). The 21 days is cumulative across the life of that pen or vial, so it cannot be reset by putting it back in the fridge. After 21 days at room temperature it must be discarded.
Can I refreeze tirzepatide if it got cold?
No. The label says do not freeze tirzepatide and do not use it if it has frozen. There is no thaw-and-use exception — a pen or vial that has frozen should be discarded, not thawed and injected.
What temperature should tirzepatide be stored at?
In the refrigerator at 36–46°F (2–8°C), kept in its original carton to protect it from light. If out of the fridge, it must stay at or below 86°F (30°C) and only for the allowed unrefrigerated window.
How do I know if my tirzepatide has gone bad?
Inspect it before every injection. The medicine should be clear and colorless to slightly yellow with no particles. If it is cloudy, discolored, has particles, or has been frozen, do not use it — discard it and use a different dose, and ask your pharmacist if you are unsure.
References(2)
- Eli Lilly and Company (manufacturer label) (2025). ZEPBOUND (tirzepatide) injection — FDA prescribing information (Section 16.2 Storage and Handling; Instructions for Use). DailyMed (NIH/NLM), FDA label. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
- Eli Lilly and Company (manufacturer label) (2025). MOUNJARO (tirzepatide) injection — FDA prescribing information (Section 16.2 Storage and Handling). DailyMed (NIH/NLM), FDA label. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Related monograph sections
View allTirzepatide: Evidence, Dosing & Side Effects
An evidence-based guide to tirzepatide: how the dual GIP/GLP-1 drug works, what the trials show, the dosing ladder, side effects, and the ongoing-use reality.
ReadTirzepatide vs Semaglutide: Head-to-Head
How tirzepatide and semaglutide compare in the trials that put them head-to-head — SURPASS-2 for glucose, SURMOUNT-5 for weight loss. The honest verdict.
ReadTirzepatide Dosing Ladder & Side Effects
The tirzepatide titration schedule from the FDA label, why the dose climbs slowly, the common GI side effects, and practical ways to manage tolerability.
ReadWhat Happens If You Stop Tirzepatide?
What the SURMOUNT-4 trial shows about weight regain after stopping tirzepatide, and why it is an ongoing therapy rather than a short course.
ReadZepbound Side Effects: Full Breakdown by Frequency
Every Zepbound (tirzepatide) side effect from the FDA label, ranked by frequency — plus the gallbladder, pancreatitis, and thyroid warnings explained.
ReadZepbound for Sleep Apnea: The New FDA Indication
In Dec 2024 the FDA approved Zepbound for moderate-to-severe OSA in adults with obesity. What SURMOUNT-OSA showed, and why it's an adjunct, not a CPAP cure.
Read